Established in 2012, GT Diagnostics (Genting TauRx Diagnosic Centre Sdn Bhd) was founded as a collaboration between Genting Berhad, a Malaysian company, and TauRx Pharmaceuticals Ltd Group, with the vision to change the diagnostic landscape and market in dementia.
In 2020 GT Diagnostics (UK) Ltd was founded as a wholly owned subsidiary of Genting TauRx Diagnosic Centre Sdn Bhd. Both companies operate under the trademark GT Diagnostics.
At GT Diagnostics, our multidisciplinary team is committed to advancing the way dementia is diagnosed and managed. Through ongoing research and innovation, we are developing practical, evidence-based tools that support both early detection and long-term monitoring.
In Knowledge & Insights you will find access to a growing collection of materials – including research papers, case studies, expert guides, and more. Whether you are seeking information for personal understanding or professional use, the hub is designed to support your journey with clear, reliable insights.
At GT Diagnostics, we are driven by a passion for advanced research and strategic collaboration, delivering accurate and accessible diagnostics that enable proactive healthcare decisions.
By combining scientific rigor, global partnerships, and a commitment to ethical and sustainable practices, we strive to enhance patient well-being and foster healthier societies for generations to come.
